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Abstract
Background: Researchers have yet to investigate the specific association between 10-μm particulate matter (PM10)
levels and the risk of graft failure, kidney disease, or the functional decline of transplanted kidneys, in kidney
transplant recipients (KTRs). Furthermore, we know very little about the association between PM10 levels and the
development of allograft rejection in transplanted kidneys. Identification of air pollution as a potential contributor
to kidney disease could help reduce future disease burden, stimulate policy discussions on the importance of
reducing air pollution with respect to health and disease, and increase public awareness of the hazards of air
pollution. We aimed to evaluate the relationship of PM10 with the risk of graft failure, mortality, and decline of graft
function in KTRs.
Methods: Air pollutant data were obtained from the Korean National Institute of Environmental Research. We then
investigated potential associations between these data and the clinical outcomes of 1532 KTRs who underwent
kidney transplantation in a tertiary hospital between 2001 and 2015. Survival models were used to evaluate the
association between PM10 concentrations and the risk of death-censored graft failure (DCGF), all-cause mortality,
and biopsy-proven rejection (BPR), over a median follow-up period of 6.31 years.
Results: The annual mean PM10 exposure after kidney transplantation was 27.1 ± 8.0 μg/m3. Based on 1-year
baseline exposure, 1 μg/m3 increase in PM10 concentration was associated with an increased risk of DCGF (hazard
ratio (HR): 1.049; 95% confidence interval (CI): 1.014–1.084) and BPR (HR: 1.053; 95% CI: 1.042–1.063). Fully adjusted
models showed that all-cause mortality was significantly associated with 1-year average PM10 concentrations (HR,
1.09; 95% CI, 1.043 to 1.140).
Conclusions: Long-term PM10 exposure is significantly associated with BPR, DCGF, and all-cause mortality in KTRs.
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Background
Exposure to outdoor air pollution is a leading cause of
global disease burden and accounts for over four million
deaths each year [1]. Increased concentrations of daily
fine particulates that are 10 μm in aerodynamic diameter
(PM10) are associated with an increased risk of cardio-
vascular disease [2, 3], stroke [4], heart failure [5, 6],
death [7], and reduced life expectancy, as well as a host
of other adverse health outcomes [1].
In a large cohort of veterans in the United States [8, 9],
higher amounts of fine particulate matter were associated
with an increased risk of incident chronic kidney disease
(CKD), a reduction in estimated glomerular filtration rate
(eGFR), and end-stage renal disease (ESRD). Experimental
laboratory evidence also indicates that long-term exposure
to micro-particles leads to disturbances in renal
hemodynamics, thus promoting oxidative stress and sys-
temic inflammation in the renal tissue; these factors exac-
erbates acute kidney injury and further promotes chronic
renal injury in murine models [10, 11].
Previous studies have focused only on evaluating the
association between PM10 and the outcomes of kidney
diseases in native kidneys. However, researchers have yet
to investigate the specific association between PM10
levels and the risk of graft failure, kidney disease, or the
functional decline of transplanted kidneys, in kidney
transplant recipients (KTRs). Furthermore, we know
very little about the association between PM10 levels
and the development of allograft rejection in trans-
planted kidneys. The identification of air pollution as a
potential contributor to kidney disease could help reduce
future disease burden, stimulate policy discussions on
the importance of reducing air pollution with respect to
health and disease, and increase public awareness relat-
ing to the hazardous nature of air pollution.
In the present study, we developed a longitudinal na-
tional cohort of KTRs and investigated the relationship
between PM10 levels and the risk of biopsy-proven re-




This was a retrospective cohort study involving data
generated between January 2001 and December 2015 at
the Seoul National University Hospital and Seoul
National University Boramae Medical Center. Initially, a
total of 1531 adult participants (> 18 years) were in-
cluded. However, a number of patients were then ex-
cluded for the following reasons: (1) multiple organ
transplantation (n = 61) and double kidney transplant-
ation (n = 85); (2) graft failure within 3months of trans-
plantation (n = 7), and (3) mortality within 3 months of
transplantation (n = 16). Only the participants whose
data included a zip code were included in the final
analysis.
We also collected a range of baseline information, in-
cluding recipient/donor age, gender, the relationship be-
tween donor and recipient, smoking status, body mass
index (BMI), the incidence of diabetes and hypertension,
chronic glomerulonephritis as a cause of ESRD, the
duration of renal replacement therapy (RRT) prior to
transplantation, and the type of previous RRT. We also
collated data relating to a range of immunological fac-
tors, including preemptive transplantation (defined by
the absence of dialysis prior to transplantation), donor
status (living or deceased), ABO incompatibility, and a
number of HLA-A, −B, and -DR mismatches.
Air pollution data
Across the South Korea, there are eleven different types
of monitoring sites operated by the Ministry of Environ-
ment and local governments. These monitoring sites are
situated across 584 locations in 114 cities and counties.
This study used data arising from 373 monitoring sta-
tions situated in both urban and roadside positions.
PM10 concentration data for 2001 and 2015 were pro-
vided by the Korean National Institute of Environmental
Research (https://www.airkorea.or.kr/web). We collated
hourly PM10 data from each of our 373 national moni-
toring sites. In addition, we used daily mean PM10 con-
centrations for individual study populations according to
the respective district of each enrolled patient, as deter-
mined by the residential address stated on medical
records.
In this study, we were interested in the effects of long-
term exposure. To examine the effect of the amount of
exposure at the time of outcome, rather than at the time
of kidney transplantation, the exposure concentration
was varied from 1 to 5 years before the clinical out-
comes. We analyzed the effects of exposure by applying
the average concentration values for each of these
periods.
Laboratory measurements and study outcomes
Graft function was assessed by determining serum
creatinine levels after transplantation. The eGFR was
calculated using the MDRD GFR equation [12]. Graft
failure was defined as an irreversible loss of graft
function with the need to restart dialysis or to undergo
re-transplantation. DCGF data were also analyzed.
Surveillance biopsies were routinely performed 1–2
weeks after transplantation in almost all patients. Add-
itional biopsies were performed when renal graft func-
tion was impaired, or when there was a considerable
reduction in urine output. Rejection was determined ac-
cording to the diagnostic criteria proposed at the 2007
Banff Conference [13], while BPRs involved acute T-cell
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mediated rejection (TCMR) and acute antibody-
mediated rejection (ABMR), and chronic rejections.
Statistical analysis
Demographic and clinical characteristics of the overall
cohort are presented as frequencies (percentages) for
categorical variables and as means (with standard devi-
ation, SD) for continuous variables.
To investigate the association between the clinical out-
comes of transplantation patients and PM10 concentra-
tion, we calculated Kaplan-Meier estimates of survivor
functions and compared survival curves between groups
of patients according to a pre-determined cut-off value,
which was defined as the median annual mean PM10
concentration.
Next, the median PM10 concentration was used to
divide PM10 data into two groups, and a log rank test
was used to test the null hypothesis. We then used the
Cox proportional hazards survival model to investigate
the association between the 1-year mean PM10 concen-
trations (for the 5-year study period) before the events
occurred, along with the individual and clinical out-
comes. Finally, we adjusted our data to take account of
covariates. As the definition of exposure was dependent
on the annual mean obtained from an air monitoring
station in each district, we also collated data from the
year prior to the event. Additionally, subgroup analysis
was performed for two groups of TCMR and ABMR ac-
cording to the mechanism of occurrence of the biopsy-
proven rejection event, one of the outcomes.
To explore whether this association was non-linear or
linear, we considered a non-linear relationship via
smoothing splines. Splines are mathematical constructs
made of fragments of polynomial functions that are
stitched together to form a smooth curve. In order to
identify a smoothing spline, we used the penalized par-
tial likelihood method; this is known to be an effective
method for survival analysis.
We used models that incorporated subject-specific
random effects to account for unmeasured subject char-
acteristics that influenced the hazard of the occurrence
of the outcome. In our research, these models were then
extended to models that incorporated cluster-specific
random effects to account for within-cluster homogen-
eity in outcomes. Moreover, we investigated whether dif-
ferent concentrations of PM10 affected the health of
kidney transplant patients using the two-pollutant model
of PM10 with adjustment for SO2, CO, NO2, and O3
and whether these effects differed by regions. All statis-
tical analyses were performed using R (3.6.0) and SAS
version 9.4.
Results
Initially, we recruited a total of 1532 individuals. How-
ever, we then excluded 240 patients aged < 19 years, 61
patients who underwent multiple organ transplantation,
and 85 patients who underwent kidney transplantation
more than twice. Consequently, our final analysis fea-
tured 1146 eligible KTRs (Fig. 1). The demographic
characteristics of the final study participants are pre-
sented in Table 1. The mean age of the recipients at the
time of kidney transplantation was 45.0 ± 12.5 years and
that of the donors was 42.6 ± 13.0 years. The majority of
the study population were males (60.12%), and 11.61%
were smokers. Overall, 91.97% of our patients were
hypertensive and 34.12% had diabetes mellitus. When
measured 6 months after transplantation, the eGFR was
56.0 ± 17.5 ml/min/1.73 m2. The incidence of preemptive
kidney transplantation was 29.8%, while that of ABO in-
compatible kidney transplantation was 5.9%. The geo-
graphic locations of the participants are shown in Figure
S1. Figure 2 shows the annual mean PM10 concentra-
tions for each year during the entire study period. The
overall mean PM10 concentration was 52.68 ± 30.49 μg/
m3. The mean PM10 exposure showed a slight increase
compared to the overall mean PM10 concentration be-
tween 2001 and 2009 (yearly mean PM10 exposure was
60.22, 59.19, 58.05, 58.85, 57.83, 55.9, 56.8, 54.22, and
53.1 μg/m3, respectively), but then a slight decrease from
2010 to 2015 (yearly mean PM10 exposure was 51.11,
49.84, 44.96, 48.89, 48.94, and 47.63 μg/m3, respectively).
Mean follow-up time was 6.3 ± 4.2 years and a total of
51 deaths (4.5%), 78 cases of DCGF (6.8%), and 549
cases of BPR (47.9%) were recorded. The Kaplan-Meier
survival curves for BPR, DCGF, and mortality were sig-
nificantly worse in the group exposed to higher
Fig. 1 Flow diagram showing patient enrollment and application of exclusion criteria
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concentrations of PM10 than in the group exposed to
lower concentrations (Fig. 3).
Overall, our data indicated that a 1 μg/m3 increase in
PM10 concentration was associated with an increased
risk of BPR (hazard ratio [HR]: 1.053; 95% confidence
interval [CI]: 1.042–1.063), graft failure (HR: 1.049; 95%
CI: 1.014–1.084), and mortality (HR: 1.090; 95% CI:
1.043–1.140) in our analyses considering exposure over
a 1-year period with regards to prospective clinical
outcome (Table 2). In addition, we performed analyses
of various PM10 exposure values, from 2-year to 5-years
(S1-S3 Tables). According to the results of this sensitiv-
ity analysis, the effect of PM10 on the clinical outcome
of kidney transplant patients consistently showed a sig-
nificant effect according to the concentration value of
PM10 over various periods. Spline analyses suggested a
linear relationship between PM10 concentration and the
risk of BPR (P-value for nonlinearity < 0.031), DCGF (P-
Table 1 Demographic and baseline characteristics of the overall study population
Variables Category Median Total
N = 1146
% Mean ± SD
Concentration Low[26.26 ~ 53.00) High[53.00 ~ 120.19)
N (%) 663 (57.85) 483 (42.15)
Recipient characteristics
Age at transplantation, years 45.12 ± 12.92 44.92 ± 11.86 45.0 ± 12.5
Sex male 405 (35.34) 284 (24.78) 689 60.12
female 258 (22.51) 199 (17.36) 457 39.88
Smoking yes 66 (5.76) 67 (5.85) 133 11.61
no 597 (52.09) 416 (36.30) 1013 88.39
Body mass index, kg/m2 22.74 ± 3.35 22.56 ± 3.25 26.2 ± 70.5
Hypertension yes 588 (51.31) 466 (40.66) 1054 91.97
no 75 (6.54) 17 (1.48) 92 8.03
Diabetes mellitus yes 229 (19.98) 162 (14.14) 391 34.12
no 434 (37.87) 321 (28.01) 755 65.88
Preemptive yes 208 (18.15) 134 (11.69) 342 29.84
no 455 (39.70) 349 (30.45) 804 70.16
RRT duration before KT, months 36.93 ± 45.44 39.78 ± 48.28 38.13 ± 46.65
Phosphorus, mg/dl 5.11 ± 6.16 4.91 ± 1.62 5.02 ± 4.82
Albumin, g/dl 5.27 ± 38.66 3.90 ± 0.61 4.69 ± 29.40
eGFR at 6 months, ml/min/1.73m2 55.30 ± 18.45 57.06 ± 16.02 56.0 ± 17.5
Diseases causing ESRD DM 119 (10.38) 70 (6.11) 189 16.49
HTN 29 (2.53) 19 (1.66) 48 4.19
GN 250 (21.82) 172 (15.01) 422 36.82
others 81 (7.07) 73 (6.37) 154 12.43
unknown 184 (16.06) 149 (13.00) 333 29.06
HLA mismatch 2.98 ± 1.76 3.01 ± 1.60 2.99 ± 1.69
Donor characteristics
Donor age, years 43.1 ± 13.14 41.80 ± 12.70 42.6 ± 13.0
Donor sex male 368 (32.11) 283 (24.69) 651 56.81
female 295 (25.74) 200 (17.45) 495 43.19
Donor type Living 452 (39.44) 325 (28.36) 777 67.8
Deceased 211 (18.41) 158 (13.79) 369 32.2
ABO compatible 621 (53.40) 466 (40.66) 1078 94.07
incompatible 51 (4.45) 17 (1.48) 68 5.93
Data are presented as means with standard deviation unless otherwise indicated. Covariates are given as measured at the time of kidney transplantation. RRT
renal replacement therapy, KT kidney transplantation, eGFR estimated glomerular filtration rate, ESRD end stage renal disease, DM diabetes mellitus, HTN
hypertension, GN glomerulonephritis, HLA human leukocyte antigen
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value for nonlinearity = 0.2), and all-cause mortality (P-
value for nonlinearity = 0.7; Fig. 4). The slope of the
mortality plot showed a linear trend. For BPR, we ob-
served a significant increasing trend in nonlinearity with
a slight flat turn after the 1-year moving average PM10
concentration of 70 μg/m3. However, only a limited
amount of data was acquired at these higher concentra-
tions, as reflected by the wide CI; this confirms our ob-
servation that a departure from linearity cannot be
established.
The results for the gamma frailty model is reported in
Table 3. The estimate of the within-cluster correlation
Fig. 2 Distribution of baseline PM10 exposure by year. Boxes display the 25-75th percentiles (interquartile range: IQR); the center line represents
the median concentration. Whiskers indicate the most extreme data within 3 IQRs of the box, while circles indicate outlying values
Fig. 3 Survival curves by median value of the annual mean PM10 concentration. (a) Biopsy-proved rejection (BPR), (b) Death-censored graft
failure (DCGF), and (c) All-cause mortality. Note: The units for the X-axis “Time” of the Kaplan meier curve are months
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of outcomes and the variance of the frailty distribu-
tion for clinical outcomes of BPR, DCGF, and all-
cause mortality was 0.05304, 0.0001, and 0.03079, re-
spectively. Thus, the within-cluster correlation of sur-
vival times was marginally greater than 0.007, 0.012,
and 0.186. After adjustment for air pollutants, the as-
sociations between PM10 and BPR and between
DCGF and all-cause mortality were significant for all
outcomes. The estimates of the hazard ratio for BPR
with one unit increase in PM10 concentration de-
creased significantly after adjustment for SO2 (0.2%),
CO (0.4%), NO2 (4.1%), and O3 (0.4%). Notably, the
hazard ratio for GF with the same increase in PM10
concentration increased by 6.2%, and the hazard ratio
for mortality increased by 6.8% after adjustment for
O3 (Table 4). As a result of subgroup analysis of two
groups according to the BPR mechanism, the hazard
ratio of PM10 was 1.053 (95% CI: 1.043–2.895) in the
TCMR group, and the HR in the ABMR group was
1.133 (95%CI:1.054–1.219), which were statistically
significant (Table 5).
Discussion
To the best of our knowledge, this is the first study to
examine the association between long-term exposure to
PM10 and clinical outcomes in KTRs. In this study, we
demonstrated that long-term exposure to higher 1-year
moving mean PM10 concentration significantly in-
creased the risk of all-cause mortality, DCGF, and BPR
in KTRs. We used the observations of the monitoring
stations at the local level and applied the average values
over several periods to conduct a sensitivity analysis. In
addition, by considering the unmeasured confounder,
the characteristic of regions, we used models with a ran-
dom effect term. When considering the within-cluster
correlation of survival times, random effects were signifi-
cant only in DCGF and BPR and not mortality. The re-
sults of both models, the model with random effects or
not, showed that PM10 had a statistically significant ef-
fect on the health of kidney transplant patients.
Several epidemiological studies have reported the asso-
ciation between particulate matter and CKD. For ex-
ample, a weak acceleration in the progression of
Table 2 Risk of outcomes in PM 10 concentration for average of 1 year from events day
BPR DCGF All-cause mortality
Variables HR 95% CI P Value HR 95% CI P Value HR 95% CI P Value
Age at transplantation 1 0.991 1.009 0.9997 0.974 0.948 1.002 0.0647 1.071 1.033 1.109 0.0001
Smoking 1.168 0.880 1.549 0.2828 1.091 0.507 2.350 0.8235 0.457 0.129 1.612 0.2233
Body mass index 1 0.999 1.001 0.6925 0.928 0.844 1.022 0.1279 0.905 0.801 1.022 0.1087
Hypertension 0.905 0.645 1.269 0.5629 1.198 0.274 5.245 0.8108 0.926 0.116 7.369 0.9422
Diabetes mellitus 0.872 0.675 1.127 0.2948 0.895 0.420 1.907 0.7731 1.167 0.502 2.710 0.72
Sex (male) 1.083 0.885 1.324 0.4382 2.232 1.213 4.107 0.0098 1.772 0.834 3.767 0.1368
HLA mismatch 1.213 1.145 1.285 <.0001 1.182 1.006 1.389 0.0419 0.995 0.805 1.230 0.9628
Cause of ESRD (DM) 1.137 0.808 1.601 0.4602 2.404 0.958 6.035 0.0618 1.381 0.515 3.704 0.521
Cause of ESRD (HTN) 0.986 0.607 1.601 0.9532 1.663 0.471 5.868 0.4291 1.367 0.375 4.983 0.6358
Cause of ESRD (GN) 0.95 0.762 1.185 0.6504 0.682 0.374 1.243 0.2113 0.603 0.256 1.419 0.2466
Cause of ESRD (others) 0.981 0.683 1.409 0.9187 a a
Phosphorus 1.047 0.989 1.108 0.1147 1.252 1.089 1.440 0.0016 1.2 0.995 1.447 0.0564
Albumin 0.885 0.781 1.002 0.0543 0.444 0.323 0.611 <.0001 0.669 0.440 1.015 0.0589
eGFR at 6 months 0.987 0.981 0.994 <.0001 0.965 0.946 0.984 0.0003 0.999 0.977 1.022 0.9439
preemptive 0.895 0.706 1.134 0.3579 0.815 0.445 1.494 0.509 0.992 0.438 2.247 0.9855
Annual mean PM10 1.053 1.042 1.063 <.0001 1.049 1.014 1.084 0.0055 1.09 1.043 1.140 0.0001
Donor age 1.012 1.004 1.020 0.0036 0.993 0.971 1.016 0.5561 1.005 0.978 1.033 0.7062
Donor sex (male) 1.146 0.944 1.392 0.1693 1.066 0.633 1.795 0.81 1.539 0.761 3.110 0.2298
Donor type (Deceased) 1.355 1.074 1.709 0.0105 1.724 0.884 3.361 0.1098 1.907 0.881 4.129 0.1015
ABO-incompatible 1.935 1.330 2.816 0.0006 1.897 0.549 6.558 0.3116 1.205 0.151 9.642 0.8602
Data are presented as mean and standard deviation unless otherwise indicated. Covariates are given as measured at the time of kidney transplantation. BPR
biopsy-proven rejection, DCGF death-censored graft failure, HLA human leukocyte antigen, ESRD end stage renal disease, DM diabetes mellitus, HTN hypertension,
GN glomerulonephritis, eGFR estimated glomerular filtration rate. The multivariable model was adjusted for age, smoking, BMI, hypertension, DM, sex, HLA
mismatch, cause of ESRD, serum phosphorus, albumin, eGFR at 6 months, preemptive, annual mean PM10, donor age, sex, donor type, and ABO-incompatible
aThese are unestimable due to the lack of the events
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albuminuria was observed during chronic exposure to
PM10 in the Multi-Ethnic Study of Atherosclerosis co-
hort. In China, long-term exposure to PM2.5 was associ-
ated with an increased risk of membranous nephropathy
in 71,151 native kidney biopsy samples [14]. Another
longitudinal observational cohort study of US veterans
reported the association between PM2.5 concentration
and a higher risk of CKD incidence and progression to
ESRD [8]. Among 21,656 Taiwanese adults [15], individ-
ual exposure to PM10, coarse particles, or PM2.5 was re-
lated to reduced renal function. In a nationwide cohort
study [9], Bowe et al. showed that higher concentrations
of PM10, NO2, and CO, were associated with increased
risks of CKD, renal function decline, and ESRD. In a re-
cent cohort study in the US observed that higher annual
PM2.5 exposure was associated the increased albumin-
uria and a higher risk of CKD [16].
In the present study, we found that elevated levels of
PM10 were consistently associated with a significantly
higher risk of adverse renal transplantation outcomes,
including DCGF, BPR, and all-cause mortality. Our sen-
sitivity analyses indicated that our results were robust,
including the examination of various exposure durations
and analyses involving fully adjusted models. We found
that PM10 affects each outcome even after adjusting for
other air pollutants. In addition, the effects of CO and
O3, which are other air pollutants that were adjusted,
were statistically significant.
Table 3 shows the covariance estimates and associated
statistics for fixed effects and the variance of frailty. As
shown in the table, the frailty value is significantly
greater than zero (θ = 0.05; p value = 0.0078). Further-
more, our result shows that there are factors that influ-
nence the hazard of BPR. It is obvious from our results,
that the districts were important (p value = 0.0078) and
gamma frailty with a covariance estimates of 0.05 shows
that there were unmeasured districts effects present in
the model.
Fig. 4 The risk of renal outcomes according to PM10 concentrations. Models were adjusted for age, sex, diabetes mellitus, hypertension, eGFR 6
months after surgery, BMI, HLA Ag Mismatch, the cause of ESRD, albumin, phosphorus, preemptive kidney transplantation, donor age, donor sex,
and donor type (deceased). a Risk of incident biopsy-proven rejections (BPR) (P for nonlinearity = 0.000032). b Risk of incident death-censored
graft failure (DCGF) (P for nonlinearity = 0.07). c Risk of all–cause mortality (P for nonlinearity = 0.4)
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The underlying biological mechanisms that may
explain the novel association between long-term PM10
exposure and renal outcomes in KTRs is unclear. Clas-
sically, the inhalation of particulate matters activates
pulmonary inflammatory cells that may trigger a sys-
temic inflammatory response that triggers a cascade of
events, ultimately affecting the body’s cardiovascular sys-
tem [17]. Recent studies have reported that the inhaled
Table 3 Risk of outcomes of 1-year average PM10 concentrations based on a random-effects model
BPR DCGF All-cause mortality
Variables HR 95% CI P Value HR 95% CI P Value HR 95% CI P Value
Age at transplantation 1 0.991 1.009 0.9275 0.974 0.948 1.002 0.0647 1.07 1.033 1.108 0.0002
Smoking 1.215 0.914 1.614 0.1806 1.091 0.507 2.350 0.8235 0.463 0.131 1.631 0.2304
Body mass index 1 0.999 1.001 0.5951 0.928 0.844 1.022 0.1279 0.904 0.800 1.022 0.1077
Hypertension 0.909 0.647 1.277 0.582 1.198 0.274 5.245 0.8108 0.93 0.117 7.397 0.9455
Diabetes mellitus 0.888 0.686 1.148 0.3631 0.895 0.420 1.907 0.7731 1.159 0.499 2.692 0.7314
Sex (male) 1.064 0.870 1.302 0.5473 2.232 1.213 4.107 0.0098 1.747 0.821 3.716 0.1477
HLA mismatch 1.217 1.149 1.289 <.0001 1.182 1.006 1.389 0.0419 1 0.808 1.237 0.9988
Cause of ESRD (DM) 1.158 0.823 1.630 0.3998 2.404 0.958 6.036 0.0617 1.417 0.528 3.804 0.4893
Cause of ESRD (HTN) 1 0.615 1.626 0.9993 1.663 0.471 5.868 0.429 1.369 0.375 4.997 0.6347
Cause of ESRD (GN) 0.955 0.765 1.193 0.6881 0.682 0.374 1.243 0.2113 0.602 0.255 1.420 0.2465
Cause of ESRD (others) 1.018 0.708 1.464 0.9218 a a
Phosphorus 1.051 0.992 1.113 0.0918 1.252 1.089 1.440 0.0016 1.204 0.997 1.454 0.0535
Albumin 0.881 0.777 0.998 0.0473 0.444 0.323 0.611 <.0001 0.67 0.440 1.021 0.0622
eGFR at 6 months 0.987 0.981 0.993 <.0001 0.965 0.946 0.984 0.0003 0.999 0.977 1.022 0.9519
preemptive 0.883 0.696 1.120 0.3042 0.815 0.445 1.494 0.509 0.999 0.440 2.266 0.9978
Annual mean PM10 1.058 1.047 1.068 <.0001 1.049 1.014 1.084 0.0055 1.093 1.046 1.142 <.0001
Donor age 1.012 1.004 1.020 0.0039 0.993 0.971 1.016 0.5561 1.005 0.978 1.033 0.7132
Donor sex 1.16 0.954 1.410 0.137 1.066 0.633 1.795 0.8099 1.537 0.760 3.112 0.2319
Donor type (Deceased) 1.365 1.080 1.725 0.0091 1.724 0.884 3.361 0.1098 1.939 0.890 4.223 0.0955
ABO-incompatible 2.002 1.374 2.918 0.0003 1.897 0.549 6.558 0.3117 1.183 0.148 9.467 0.8743
Random Covariance estimates(θ) p-value Covariance estimates(θ) p-value Covariance estimates(θ) p-value
regions 0.05304 0.0078 0.0001 0.0128 0.03079 0.1866
Data are presented as mean and standard deviation unless otherwise indicated. Covariates are given as measured at the time of kidney transplantation. BPR
biopsy-proven rejection, DCGF death-censored graft failure, HLA human leukocyte antigen, ESRD end stage renal disease, DM diabetes mellitus, HTN hypertension,
GN glomerulonephritis, eGFR estimated glomerular filtration rate. The multivariable model was adjusted for age, smoking, BMI, hypertension, DM, sex, HLA
mismatch, cause of ESRD, serum phosphorus, albumin, eGFR at 6 months, preemptive, annual mean PM10, donor age, sex, donor type, ABO-incompatible and
random effect (region)
aThese are unestimable due to the lack of the events
Table 4 Hazard Ratio in association with annual average concentration of PM10 after adjusting for co-pollutants
BPR DCGF All-cause mortality
HR 95%CI HR 95%CI HR 95%CI
Single pollutant model of PM10 1.053 1.042 1.063 1.049 1.014 1.084 1.09 1.043 1.140
PM10 with adjustment for SO2 (sulfur dioxide) 1.051 1.040 1.062 1.046 1.011 1.081 1.084 1.037 1.133
Single pollutant model of PM10 1.053 1.042 1.063 1.049 1.014 1.084 1.09 1.043 1.140
PM10 with adjustment for CO (carbon monoxide) 1.049 1.038 1.059 1.037 1.001 1.073 1.075 1.027 1.125
Single pollutant model of PM10 1.053 1.042 1.063 1.049 1.014 1.084 1.09 1.043 1.140
PM10 with adjustment for NO2 (Nitrogen dioxide) 1.012 1.004 1.020 1.048 1.013 1.084 1.09 1.042 1.139
Single pollutant model of PM10 1.053 1.042 1.063 1.049 1.014 1.084 1.09 1.043 1.140
PM10 with adjustment for O3 (Ozone) 1.049 1.039 1.060 1.111 1.071 1.152 1.142 1.086 1.201
BPR biopsy-proven rejection, DCGF death-censored graft failure
Adjusted covariates: age, smoking, BMI, hypertension, DM, sex, HLA mismatch, cause of ESRD, serum phosphorus, albumin, eGFR at 6 months, preemptive, annual
mean PM10, donor age, sex, donor type, and ABO-incompatible
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nanoparticles rapidly translocate from the pulmonary
tissues into the vascular systemic circulation and subse-
quently accumulate in various organs, such as the heart,
liver, and kidneys; these observations have been made in
studies involving both animals and humans [18–21].
These particles have the capacity to induce pulmonary
inflammation and oxidative stress; parallel pathways can
also be activated in the systemic circulation and organ
systems. Research has also shown that inflammatory
markers, including C-reactive protein, fibrinogen, white
blood cell counts, and IL-6, are positively associated with
PM exposure [22, 23], and that short-term changes in
PM concentrations cause alterations in these key inflam-
matory biomarkers [24, 25].
Other studies have investigated kidney damage follow-
ing sub-chronic exposure to PM2.5 by analyzing the
levels of early kidney biomarkers, histological changes,
induction of the angiotensin and bradykinin system, and
by measuring changes in blood pressure [26, 27]. In a
previous study, involving an animal model, long-term
exposure to PM2.5 was associated with kidney damage,
including inflammatory cell infiltration, tubulo-
interstitial fibrosis, and mesangial expansion; collectively,
these effects caused an impairment in renal function
[28].
Our data showed that prolonged long-term exposure
to PM10 was associated with higher risks of transplant
kidney rejections in KTRs. However, there is little in the
current literature to explain the relationship between
PM10 exposure and the risk of graft rejections. However,
there is some evidence originating from studies involving
the recipients of other transplanted organs, such as lung
transplant recipients that suggests that PM may trigger
rejection of the transplanted organ. Recent studies have
reported that exposure to traffic-related air pollution in-
dependently increased the risk of bronchiolitis obliterans
syndrome, a condition that is clinically correlated with
chronic rejection in lung transplant patients [29], and
also associated with the development of chronic lung
allograft dysfunction, a condition that is related to both
acute and chronic allograft rejections [30, 31]. Acute re-
jection presents a major problem after organ
Table 5 The results of subgroup analysis by types of BPR
TCMR ABMR
Variables HR 95% CI P Value HR 95% CI P Value
Age at transplantation 0.998 0.989 2.739 0.6959 1.073 1.016 1.134 0.0117
Smoking 1.148 0.846 4.277 0.3769 3.067 0.535 17.590 0.2085
Body mass index 1 0.995 2.730 0.8204 0.986 0.843 1.154 0.8641
Hypertension 0.999 0.675 4.017 0.9963 0.624 0.102 3.803 0.6089
Diabetes mellitus 0.884 0.675 3.171 0.3698 0.569 0.142 2.282 0.4263
Sex (male) 1.152 0.929 3.922 0.1963 0.441 0.138 1.406 0.1661
HLA mismatch 1.219 1.147 3.596 <.0001 1.19 0.843 1.680 0.3219
Cause of ESRD (DM) 1.153 0.803 4.552 0.44 0.826 0.108 6.312 0.8539
Cause of ESRD (HTN) 1.065 0.652 4.738 0.8025 a
Cause of ESRD (GN) 0.945 0.745 3.263 0.6416 1.682 0.486 5.818 0.4116
Cause of ESRD (others) 1.032 0.706 4.104 0.8693 0.406 0.036 4.564 0.4652
Phosphorus 1.042 0.981 3.010 0.1828 0.995 0.686 1.442 0.9773
Albumin 0.906 0.791 2.835 0.1528 0.652 0.328 1.297 0.2231
eGFR at 6 months 0.989 0.982 2.707 0.0012 1.001 0.962 1.041 0.9796
preemptive 0.869 0.672 3.083 0.2849 1.062 0.329 3.432 0.9196
Annual mean PM10 1.053 1.043 2.895 <.0001 1.133 1.054 1.219 0.0008
Donor age 1.014 1.006 2.780 0.0009 0.998 0.953 1.044 0.9208
Donor sex 1.13 0.918 3.808 0.2491 2.051 0.604 6.957 0.2497
Donor type (Deceased) 1.348 1.057 4.913 0.0162 0.525 0.261 4.241 0.9435
ABO-incompatible 1.179 0.701 5.474 0.5346 5.89 1.184 29.297 0.0303
Data are presented as mean and standard deviation unless otherwise indicated. Covariates are given as measured at the time of kidney transplantation. TCMR
acute T-cell mediated rejection, ABMR acute antibody-mediated rejection, DCGF death-censored graft failure, HLA human leukocyte antigen, ESRD end stage renal
disease, DM diabetes mellitus, HTN hypertension, GN glomerulonephritis, eGFR estimated glomerular filtration rate. The multivariable model was adjusted for age,
smoking, BMI, hypertension, DM, sex, HLA mismatch, cause of ESRD, serum phosphorus, albumin, eGFR at 6 months, preemptive, annual mean PM10, donor age,
sex, donor type, and ABO-incompatible
ahese are unestimable due to the lack of the events
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transplantation, and is a recognized risk factor for
chronic rejection and all-cause mortality. The authors of
these previous papers provided evidence for the in-
creased risk of rejection after lung transplantation with
temporal changes in particulate air pollution, and re-
ported this was associated with bronchoalveolar lavage
neutrophilia and lymphocytosis. This tissue damage was
explained by the novel effect of PM on Th17
polarization via the aryl hydrocarbon receptor [32].
However, the precise biological mechanisms by which
exposure to PM10 can trigger kidney rejection is not yet
fully understood. One explanation is that the inhaled
PM may directly or indirectly induce oxidative stress
and inflammation in the transplanted kidney and that
this induces endothelial cell dysfunction and exacerbates
the production of reactive oxygen species. These compli-
cated processes may be responsible for shifting the im-
mune responses to an effector phenotype, thus leading
to the loss of self-tolerance and a shift towards allograft
rejection. Further preclinical and epidemiological studies
are now required to investigate the association between
air pollution and allograft rejection, especially in KTRs.
One particular strength of our study is that we in-
vestigated a large contemporary Korean cohort of
KTRs with a long-term follow-up of 15 years. Because
we had access to comprehensive long-term air pollu-
tant data, we were able to adjust the data for multiple
donors and recipient variables. Moreover, this study
used BPR data as the chief outcome to evaluate the
impact of PM10. However, this study also has several
limitations that need to be considered. First, the study
participants were mostly South Koreans; therefore, the
findings may not be generalizable to other popula-
tions. Although we accounted for known confounding
factors, and region with frailty survival analysis, we
cannot ignore the possibility and potential effects of
unknown or non-measured confounders. Therefore, if
the sample size of the study was large, and subjects
were evenly distributed in the sub-regional unit, it
can be carefully assumed that the effect of size on
the region may increase.
Conclusions
In summary, we demonstrate a significant association
between PM10 concentrations and the risk of graft fail-
ure development, all-cause mortality, and BPR in KTRs.
Continued efforts to improve air quality may help to re-
duce the burden of renal outcome in KTRs.
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